Table 2.

Clinical characteristics of cohort (n = 12,016)

	n	%
General characteristics
Body mass index (BMI)
<25	5,723	47.6
≥25 to <30	3,804	31.7
≥30	1,468	12.2
Missing	1,021	8.5
Alcohol abuse diagnosed	76	0.6
Diabetes	1,327	11.0
Liver-specific characteristics
Months since first CHB diagnosisa
<12	1,040	8.6
12–59	3,686	30.7
60–119	4,287	35.7
120+	3,003	25.0
Most recent ALT levelsb, c
Normal	5,337	44.4
>1–2× ULN	3,154	26.3
>2× ULN	758	6.3
Not tested	2,767	23.0
Most recent viral load (IU/ml)b
<2 k	3,316	27.6
2–20 k	711	5.9
>20 k	706	5.9
Not tested	7,283	60.6
Most recent HBeAg statusc
Positive	1,157	9.6
Negative	8,437	70.2
Not tested	2,422	20.2
Cirrhosisb	195	1.6
Incident HCCb	28	0.2

CHB denotes chronic hepatitis B. Data reflect 10,367 individuals on treatment and 1,649 not on treatment during the 18-month study window

^aAs of July 1, 2009

^bDocumented during 18-month study window

^cStandardized upper limit of normal (ULN) ALT of 19 for women and 30 for men

^dMost recent since 1995